Structural Mechanisms of Human Phosphatidylserine Synthase 2 in SREBP Pathway Regulation

Study Background and Research Question

Phosphatidylserine (PS) is a fundamental phospholipid in eukaryotic cell membranes, contributing to membrane structure and diverse signaling pathways. The synthesis of PS in mammalian cells is catalyzed by two homologous enzymes: phosphatidylserine synthase 1 (PSS1) and phosphatidylserine synthase 2 (PSS2). Despite sharing approximately 40% amino acid identity, these enzymes differ in substrate preference—PSS1 utilizes both phosphatidylethanolamine (PE) and phosphatidylcholine (PC), while PSS2 is selective for PE. Previous studies established that PSS1 deficiency activates the sterol regulatory element-binding protein 2 (SREBP2) pathway, affecting cholesterol metabolism. However, the precise molecular distinction between PSS1 and PSS2 in substrate selection and their respective roles in SREBP-mediated lipid regulation remained unclear. The current study addresses these knowledge gaps by resolving the structure of human PSS2 and elucidating its functional impact on lipid homeostasis and SREBP pathways (reference study).

Key Innovation from the Reference Study

The central innovation lies in the high-resolution cryo-electron microscopy (cryo-EM) structure of human PSS2 at 3.3 Å, combined with molecular dynamics simulations and lipidomic analyses. This integrated approach provides molecular insight into why PSS2 only utilizes PE, establishing a structural basis for its substrate specificity. Furthermore, the study demonstrates that, contrary to its homology with PSS1, PSS2 deficiency leads to increased PE levels and suppresses cleavage of both SREBP-1 and SREBP-2—an effect opposite to that observed with PSS1 inhibition. This reveals a previously unrecognized divergence in the regulation of lipid metabolic pathways by these two enzymes.

Methods and Experimental Design Insights

The experimental workflow employed a combination of gene knockout strategies, structural biology, and lipidomics in mammalian cell models:

• Gene editing was used to generate Ptdss1 and Ptdss2 knockout CHO-K1 cell lines, enabling the dissection of individual enzyme contributions.
• Quantitative RT-PCR was performed to assess the relative expression of PSS1 and PSS2 at the mRNA level, revealing that PSS2 is expressed at about 30% the level of PSS1 in wild-type cells.
• Cryo-EM was utilized to resolve the structure of human PSS2, allowing for detailed comparison of its catalytic cavity with PSS1.
• Molecular dynamics simulations provided insight into substrate binding and specificity, clarifying why PSS2 does not accommodate PC as a substrate.
• Lipidomic profiling characterized the phospholipid composition of ER membranes in the knockout models, especially focusing on PE and PS levels.
• SREBP cleavage was assessed biochemically to determine the functional impact of altered phospholipid metabolism.

This comprehensive methodology enabled the authors to link enzyme structure, substrate preference, and downstream regulatory effects.

Core Findings and Why They Matter

The study's pivotal findings are as follows:

• PSS2 Substrate Selectivity: The cryo-EM structure and simulation data reveal that the catalytic cavity of PSS2 is structurally constrained to accept only PE, unlike PSS1, which can accommodate both PE and PC. This is attributed to specific amino acid differences lining the substrate-binding pocket (reference study).
• Divergent Regulation of SREBP Pathways: While PSS1 inhibition activates SREBP2 by disrupting PS synthesis and Aster-mediated cholesterol transport, PSS2 deficiency was shown to increase PE in the ER and inhibit cleavage of both SREBP-1 and SREBP-2. This indicates that elevated ER PE can serve as a negative regulator of SREBP activation, independent of cholesterol trafficking mechanisms.
• Functional Non-Redundancy of Homologs: Despite their high sequence similarity, PSS1 and PSS2 have diverged to play opposing roles in the regulation of lipid homeostasis and SREBP activation. This highlights the importance of substrate specificity in dictating broader cellular functions.

These insights refine the understanding of how phospholipid metabolism interfaces with key lipid regulatory pathways, suggesting that modulation of individual synthases can have nuanced effects on cellular lipid balance and signaling.

Comparison with Existing Internal Articles

Several internal articles provide complementary perspectives on the technical tools and strategies used in studies of lipid metabolism and protein regulation:

• The article "3X (DYKDDDDK) Peptide: Optimizing ER Protein Folding and Detection" discusses applications of the 3X FLAG peptide in the study of ER-resident proteins, including affinity purification of FLAG-tagged proteins and mechanistic dissection of ER chaperones. Such strategies are relevant for investigating the localization and function of lipid synthesis enzymes like PSS2.
• "3X (DYKDDDDK) Peptide: Next-Gen Epitope Tag for Protein Purification" emphasizes how high-sensitivity epitope tags facilitate workflows for immunodetection of FLAG fusion proteins and protein crystallization with FLAG tag—methods directly applicable to the structural and functional studies exemplified in the PSS2 cryo-EM research.
• Further, the "3X (DYKDDDDK) Peptide: Precision Epitope Tag" article elaborates on the value of hydrophilic, compact epitope tags for advancing reproducible affinity purification and metal-dependent ELISA assay workflows, supporting the robust isolation and analysis of membrane proteins involved in lipid metabolism.

Together, these internal resources highlight the synergy between advanced biochemical tools such as the 3X FLAG peptide and mechanistic studies of membrane protein function and regulation.

Limitations and Transferability

While the study provides high-resolution structural and functional data on PSS2, several limitations should be considered:

• The primary cellular model was hamster CHO-K1 cells, which, although widely used, may not fully recapitulate all aspects of human lipid metabolism or tissue-specific regulation.
• Functional outcomes were observed under knockout or deficiency conditions; the effects of more subtle modulation or physiological regulation of PSS2 remain to be explored.
• The study's focus was on the ER-localized pool of PE and PS; the broader impact on other organelles or on systemic lipid metabolism will require further investigation.
• Direct transferability of findings to in vivo models or clinical contexts should be approached with caution until validated in additional systems.

Despite these caveats, the mechanistic principles uncovered are likely to inform future studies of phospholipid synthases and their role in lipid regulatory networks.

Protocol Parameters

• Ptdss2 knockout design: Employ CRISPR/Cas9-mediated gene editing in CHO-K1 or human cell lines to generate targeted deletions; validate by RT-PCR and immunoblotting.
• Lipid extraction for ER lipidomics: Harvest cells at 80-90% confluency, perform subcellular fractionation to isolate ER membranes, and use mass spectrometry-based lipid profiling.
• Cryo-EM sample preparation: Purify FLAG-tagged PSS2 or related membrane proteins using affinity purification of FLAG-tagged proteins; concentrate samples to ≥1 mg/mL for grid preparation.
• SREBP cleavage assays: Treat cells with or without PSS1/PSS2 inhibition, extract nuclear and cytoplasmic fractions, and detect SREBP fragments by immunodetection of FLAG fusion proteins or endogenous markers.
• Protein crystallization with FLAG tag: Use high-purity, hydrophilic FLAG-tagged protein preparations; ensure compatibility with downstream metal-dependent ELISA assay or structural analysis.

Research Support Resources

For researchers seeking to replicate or extend these workflows, the 3X (DYKDDDDK) Peptide (SKU A6001) from APExBIO offers a reliable option for affinity purification, detection, and protein crystallization involving FLAG-tagged membrane proteins. Its hydrophilic trimeric design ensures minimal interference with protein structure and function, supporting sensitive workflow requirements discussed in both the reference study and internal literature resources.